Blog Archive

0

APO-Fluconazole (fluconazole) Drug / Medicine Information

Contains the active ingredient fluconazole

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about fluconazole. It does not contain all the available information. It does not
take the place of talking to your doctor or pharmacist.

The information in this leaflet was last updated on the date listed on the last page. More recent information on your medicine
may be available.

Ask your doctor or pharmacist:

if there is anything you do not understand in this leaflet,

if you are worried about taking your medicine, or

to obtain the most up-to-date information.

You can also download the most up to date leaflet from www.apotex.com.au.

All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they
expect it will have for you.

Pharmaceutical companies cannot give you

Read More
0

APO-Duloxetine (duloxetine) Drug / Medicine Information

Contains the active ingredient duloxetine (as duloxetine hydrochloride)

Consumer Medicine Information

What is in this leaflet

This leaflet answers some common questions about this medicine. It does not contain
all the available information. It does not take the place of talking to your doctor
or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking
this medicine against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine.

You may need to read it again.

What this medicine is used for

Duloxetine is used to treat:

major depressive disorder (MDD)

generalised anxiety disorder (GAD) – excessive worry

Duloxetine belongs to a group of medicines called serotonin and noradrenaline reuptake
inhibitors (SNRIs). SNRIs are believed to work by their action on serotonin and noradrenaline
in the

Read More
0

Bi Eligard cp (bicalutamide & leuprorelin acetate) Drug / Medicine Information

bicalutamide & leuprorelin acetate

Consumer Medicine Information

What is in this leaflet

This leaflet answers some common questions about Bi ELIGARD cp. It does not contain
all the available information. It does not take the place of talking to your doctor
or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you taking
Bi ELIGARD cp against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine.

You may need to read it again.

What Bi ELIGARD cp is used for

Bi ELIGARD cp combination therapy is the brand name for packs containing ELIGARD (leuprorelin
acetate) 7.5 mg or 22.5 mg subcutaneous injection plus MPL-BICALUTAMIDE 50 mg tablets.

Bi ELIGARD cp is used to reduce the symptoms of advanced cancer of the prostate gland.

Bicalutamide tablets

Read More
0

APO-Naltrexone (Naltrexone) Drug / Medicine Information

Contains the active ingredient Naltrexone (as Naltrexone Hydrochloride)

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about naltrexone. It does not contain all the available information. It does not
take the place of talking to your doctor or pharmacist. Your doctor has been provided with full information and can answer
any questions you may have. Follow your doctor’s advice even if it is different from what is in this leaflet.

The information in this leaflet was last updated on the date listed on the last page. More recent information on this medicine
may be available.

Ask your doctor or pharmacist:

if there is anything you do not understand in this leaflet,

if you are worried about taking your medicine, or

to obtain the most up-to-date information.

You can also download the most up to date leaflet

Read More
0

APO-Exemestane (exemestane) Drug / Medicine Information

Contains the active ingredient exemestane

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about exemestane. It does not contain all the available information. It does not
take the place of talking to your doctor or pharmacist.

The information in this leaflet was last updated on the date listed on the last page. More recent information on this medicine
may be available.

Ask your doctor or pharmacist:

if there is anything you do not understand in this leaflet,

if you are worried about taking your medicine, or

to obtain the most up-to-date information.

You can also download the most up to date leaflet from www.apotex.com.au.

All medicines have risks and benefits. Your doctor has weighed the risks of you using this medicine against the benefits they
expect it will have for you.

Pharmaceutical companies cannot give you

Read More
0

70% of Covid-19 patients in Rwanda are men, here’s why | The New Times

The coronavirus pandemic has affected each and every country in this world.

However, this virus surfaced at a time when the use of technology to collect and analyze data is at advanced levels many have never seen before.

 

In analyzing the data from Rwanda, one of the notable interpretation of the information is how more men are getting infected as compared to women.

 

Data from the Rwanda Biomedical Centre (RBC) the organisation at the forefront of fighting the pandemic, shows that nearly 70 per cent of active infections in Rwanda are men.

 

As of August 24, Rwanda had recorded 3,089 active Covid-19 cases, of which 2,124 (68.76 per cent) infections were from men while 965 infections were from women.

To understand the reason behind the high infection rates among men, The New Times reached out to various experts.

Dr Sabin Nsanzimana, the Director-General at RBC attributed the gender disparity in

Read More
0

Chemmart Atenolol (atenolol) Drug / Medicine Information

Contains the active ingredient, atenolol

Consumer Medicine Information

What is in this leaflet

Read this leaflet carefully before taking your medicine.

This leaflet answers some common questions about atenolol. It does not contain all
the available information. It does not take the place of talking to your doctor or
pharmacist.

The information in this leaflet was last updated on the date listed on the last page.
Some more recent information on the medicine may be available. You should ensure that
you speak to your pharmacist or doctor to obtain the most up to date information on
the medicine.

All medicines have risks and benefits. Your doctor has weighed the risk of you taking
atenolol against the benefits it is expected to have for you.

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine.

You may want to read it

Read More
0

Levetiracetam APOTEX (levetiracetam) Drug / Medicine Information

Contains the active ingredient levetiracetam

Consumer Medicine Information

What is in this leaflet

This leaflet answers some common questions about this medicine. It does not contain
all the available information. It does not take the place of talking to your doctor
or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of you being
given this medicine against the benefits they expect it will have for you.

If you have any concerns about being given this medicine, ask your doctor or pharmacist.

Keep this leaflet with the medicine.

You may need to read it again.

What this medicine is used for

The name of your medicine is Levetiracetam APOTEX Solution for Infusion. It contains
the active ingredient levetiracetam.

It is used to control epilepsy.

Epilepsy is a condition where you have repeated seizures. There are many different
types of seizures, ranging from mild to severe.

Levetiracetam

Read More
0

Bisolvon Pholcodine Dry Forte Oral Liquid (Pholcodine) Drug / Medicine Information

Pholcodine

Consumer Medicine Information (CMI)

What is in this leaflet

This leaflet answers some common questions about Bisolvon Pholcodine Dry Forte Oral
Liquid.

It does not contain all the available information.

It does not take the place of talking to your pharmacist or doctor.

All medicines have risks and benefits. Your pharmacist or doctor has weighed the risks
of you taking Bisolvon Pholcodine Dry Forte Oral Liquid against the benefits they
expect it will have for you.

If you have any concerns about this medicine, ask your pharmacist or doctor.

This leaflet was last updated on the date at the end of this leaflet. More recent
information may be available. The latest Consumer Medicine Information is available
from your pharmacist, doctor, or from www.medicines.org.au and may contain important
information about the medicine and its use of which you should be aware.

Keep this leaflet with your medicine.

You may need

Read More
0

New study: Poor quality hydroxychloroquine a warning for future COVID cures | American Enterprise Institute

When President Trump promoted the malaria drug
hydroxychloroquine as a possible treatment for COVID-19 in the spring, demand
for the product jumped. Most of the subsequent debate has been about the
efficacy of the drug as a treatment for prophylaxis for COVID-19. But arguably as
important is what happens to the market when a new cure or treatment is
developed. The market for hydroxychloroquine provides some lessons.

A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege, Belgium, June16, 2020. REUTERS/Yves Herman

As I report in my new paper, the quality of the hydroxychloroquine available on the web was not universally good. Over three months (late April to early July) the drug was procured from international web pharmacies. Using a handheld spectrometer, quality was assessed in line with previous peer review studies. 48 samples were bought

Read More